Evaluation of the Impact of an Oral and Practical Presentation of Intrauterine Devices by a Health Professional on Women's Opinion as a Possible Contraceptive Method

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-14

Study Completion Date

2022-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns.

Intrauterine devices (IUDs) are the leading reversible contraceptive method used in the world, but only 20.7% of women in France were using them in 2010.

In practice, in France, use of the IUD is still "reserved" for older women or those who have already had children, despite medical recommendations.

In this study the investigator will investigate whether clear information about the mode of action and insertion/withdrawal of IUDs would dispel these misconceptions of patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Pain Level During Intrauterine Device (IUD) Insertion Between Conventional and Direct Method

NCT03473717

IUD Insertion

UNKNOWN NA

Study Assessing the Reduction of Pain Felt During Installation Intra- Uterine Device by Direct Technique

NCT02595125

Contraception

COMPLETED NA

DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users.

NCT01731132

Contraception

COMPLETED

Surveillance Study of the Contraceptive Intrauterine Device UT380®

NCT03642171

Contraceptive; Complications, Intrauterine

COMPLETED

HR-QoL and Sexuality in Mirena Inserted Contraception Users

NCT00498784

Contraception

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns.

Intrauterine devices (IUDs) are the leading reversible contraceptive method used in the world, but only 20.7% of women in France were using them in 2010.

In practice in France, the use of IUDs is still "reserved" for older women or those who have already had children, despite medical recommendations. Indeed, there is a certain feeling of mistrust towards the IUD as a contraceptive method. Sometimes the patient's reasons for refusal were unclear or misconceptions and prejudices prevailed.

Various research studies and theses have identified the various obstacles to the use of the IUD as a contraceptive. Today it would be interesting to evaluate whether a short presentation of the IUD during a consultation would lead to a better acceptance of women to use it as a possible contraceptive method.

In this study the investigators will investigate whether clear information about the mode of action and insertion/removal of IUDs would dispel these misconceptions of patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acceptance Processes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Single-centre, prospective, randomised, open-label study comparing a group of patients who had information and demonstration about IUDs prior to completing a questionnaire and a group of patients who did not have information and demonstration about IUDs prior to completing the questionnaire

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

without device information

this group of patients will complete a questionnaire before receiving information on contraceptive intrauterine devices (copper or hormonal)

Group Type OTHER

Group A, who will complete a questionnaire before receiving information about intrauterine devices

Intervention Type OTHER

Group A will complete a questionnaire before receiving information about intrauterine devices and a demonstration of insertion/removal on a plastic dummy uterus.

with device information

This group of patients will receive information about contraceptive intrauterine devices (copper or hormonal) before completing a questionnaire

Group Type OTHER

Group B who will answer a questionnaire after having the information about the intrauterine devices

Intervention Type OTHER

Group B will complete a questionnaire after receiving information about IUDs and a demonstration of insertion/removal on a plastic dummy uterus.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Group A, who will complete a questionnaire before receiving information about intrauterine devices

Group A will complete a questionnaire before receiving information about intrauterine devices and a demonstration of insertion/removal on a plastic dummy uterus.

Intervention Type OTHER

Group B who will answer a questionnaire after having the information about the intrauterine devices

Group B will complete a questionnaire after receiving information about IUDs and a demonstration of insertion/removal on a plastic dummy uterus.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any woman aged 18 years and over who comes to a family planning centre
* Having expressed her free and informed written consent
* Affiliated to a social security scheme

Exclusion Criteria

* Women under 18 years of age
* Woman with an IUD
* Woman who has had an IUD before
* Woman whose reason for consultation of the day is the insertion of an IUD
* Menopausal woman
* Woman who is infertile for any reason
* Illiterate woman or woman who does not read French
* Refusal to participate in the protocol
* Incapable of age.
* Pregnant or breastfeeding women
* Vulnerable persons and protected persons as provided for in the Public Health Code Public Health Code (articles L. 1121-5 to L.1121-8 and L.1122-1-2).

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No